Venous obstruction after pacemaker implantation

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 2, 2007, Pages 199-206

  Korkeila, Petri ^a,c   Nyman, Kai ^a   Ylitalo, Antti ^b   Koistinen, Juhani ^a   Karjalainen, Pasi ^b   Lund, Juha ^a   Airaksinen, K E Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c NONE   (Finland)

Author keywords

Adverse events; Biventricular pacemaker; Cardioverter defibrillator; Pacemaker; Venography; Venous occlusion; Venous stenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD VESSEL DIAMETER; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; DEFIBRILLATOR; ELECTRODE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PROSPECTIVE STUDY; STENOSIS; VEIN OCCLUSION;

AGED; CARDIAC PACING, ARTIFICIAL; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 33847421854     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00650.x     Document Type: Article

References (25)

1. Bracke FA, Meijer A, van Gelder B. Venous occlusion of the access vein in patients referred for lead extraction: Influence of patient and lead characteristics. Pacing Clin Electrophysiol 2003; 26:1649-1652.
2. Barakat K, Robinson NM, Spurrell RAJ. Transvenous pacing lead-induced thrombosis: A series of cases with a review of the literature. Cardiology 2000; 93:142-148.
3. Martinez-Selles M, Bueno H, Almendral J, Diaz-Castro O. Pulmonary embolism after pacemaker implantation. Tex Heart Inst J 2001; 28:318-319.
4. Van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij M, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 2004; 15:1258-1262.
5. Hingorani A, Ascher E, Markevich N, Yorkovich W, Schutzer R, Mutyala M, Nahata S, et al. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J Vasc Surg 2005; 41:476-478.
6. Bolad I, Karanam S, Mathew D, John R, Piemonte T, Martin D. Percutaneous treatment of superior vena cava obstruction following transvenous device implantation. Catheter Cardiovasc Interv 2005; 65:54-59.
7. Park HW, Kim W, Cho JG, Kang JC. Multiple pacing lead-induced superior vena cava syndrome. J Cardiovasc Electrophysiol 2005; 16: 221-223.
8. Teruya TH, Abou-Zamzam AM, Limm W, Wong L, Wong L. Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers. Ann Vasc Surg 2003; 17:526-529.
9. Geller MJ, Isner JM, Payne DD, Salem DN. Limb loss due to transvenous endocardial pacemaker therapy. Am JMed 1985; 78:351-354.
10. Zuber M, Huber P, Fricker U, Buser P, Jager K. Assessment of the subclavian vein in patients with transvenous pacemaker leads. Pacing Clin Electrophysiol 1998; 21:2621-2630.
11. Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis Cl. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. Review. J Int Cardiac Electrophysiol 2005; 13:9-19.
12. Wahbi Z, Fonfe G, Weston CFM. Bilateral subclavian vein thrombosis soon after pacemaker insertion. Int J Cardiol 1996; 54:272-276.
13. Ciocon and Galindo-Ciocon. Arm edema, subclavian thrombosis, and pacemakers - a case report. Angiology 1998; 49:315-319.
14. Wierzbowska K, Krzeminska-Pakula M, Marszal-Marciniak M, Drozdz J, Zaslonka J, Kasprzak JD. Symptomatic atrial pacemaker lead thrombosis: Detection by echocardiography and successful surgical treatment. Pacing Clin Electrophysiol 2001; 24:391-393.
15. Da Costa SS, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: A 6-month follow-up prospective study. Pacing Clin Electrophysiol 2002; 25:1301-1306.
16. Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol 2002; 25:1605-1611.
17. Sticherling C, Chough SP, Baker RL, Wasmer K, Oral H, Tada H, Horwood L, et al. Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am Heart J 2001; 141:813-816.
18. Lickfett L, Bitzen A, Arepally A, Nasir K, Wolpertd C, Jeonga KM, Krausea U, et al. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 2004; 6:25-31.
19. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Dougías PS, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography, www.americanheart.org
20. Inoue H, Nozawa T, Okumura K, Jong-Dae L, Shimizu A, Yano K. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest 2004; 126:687-692.
21. Conway DSG, Buggins P, Hughes E, Lip GYH. Realtionship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 2004; 43:2075-2082.
22. Thambidorai SK, Parakh K, Martin DO, Shah TK, Wazni O, Jasper SE, VanWagoner DR, et al. Relation of c-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol 2004; 94:805-807.
23. Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GYH. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol 2006 Mar 1; 97:671-675.
24. Kotlyar E, Vita JA, Winter MR, Awtry EH, Siwik DA, Keaney Jr. JF, Sawyer DB, et al. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. J Card Fail 2006; 12:122-127.
25. Marcucci R, Gori AM, Giannott F, Baldi M, Verdiani V, Del Pace S, Nozzoli C, et al. Markers of hypecoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemostat 2006; 4:1017-1022.